PGL 0.00% 85.0¢ prospa group limited.

I think it will sink to around $4. There is a lot of tough...

  1. 580 Posts.
    I think it will sink to around $4. There is a lot of tough competition for this drug, and even if it is approved, I think the sales will be poor. The side-effects put it at a marked disadvantage to new-generation RNAI therapeutics.
 
watchlist Created with Sketch. Add PGL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.